Two cases of type 2 diabetes mellitus in elderly patients successfully treated with monthly exenatide long‐acting release

Two elderly patients with poorly controlled type 2 diabetes mellitus had difficulty self‐managing their medications. Exenatide long‐acting release (LAR), with an extended administration interval of 1 month, maintained hemoglobin A1c (HbA1c) level in the 7% range. Monthly administration of exenatide‐...

Descripción completa

Detalles Bibliográficos
Autores principales: Takenaka, Kenchi, Nishitani, Rie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509896/
https://www.ncbi.nlm.nih.gov/pubmed/31110729
http://dx.doi.org/10.1002/ccr3.2139
Descripción
Sumario:Two elderly patients with poorly controlled type 2 diabetes mellitus had difficulty self‐managing their medications. Exenatide long‐acting release (LAR), with an extended administration interval of 1 month, maintained hemoglobin A1c (HbA1c) level in the 7% range. Monthly administration of exenatide‐LAR may be considered for use in carefully selected elderly individuals.

Ejemplares similares